Canaccord Genuity as the lead underwriter in DMG Blockchain Solutions' C$17-million offering of units
Cormark Securities, as co-lead underwriter with Canaccord Genuity, in connection with a bought deal financing of common shares of Tantalus Systems Holding Inc. for gross proceeds of approximately C$10-million
HASSLACHER Group, as Canadian Counsel in its significant investment in Element5.
CrowdCare Corporation dba Wysdom.AI in its sale to Calabrio, a portfolio company of Thoma Bravo.
Clearpath Robotics Inc., a leader in autonomous robotics, in its sale to Rockwell Automation, Inc.
PI Financial Corp. and Echelon Wealth Partners Inc. and their affiliates in their merger to create a leading investment advisory, wealth management, and capital markets firm.
EQT Partners Inc., as Canadian counsel, in the sale of First Transit Inc., one of the largest private-sector operators of mobility solutions in North America, to Transdev North America Inc.
Canaccord Genuity Corp., as lead agent, in connection with a brokered "best efforts" private placement of green bonds of UGE International Ltd., for gross proceeds of approximately $7.4-million.
Wilson 5 Foundation, with respect to its commitment of $100,000,000 to the B.C. Parks Foundation.
Field Trip Health Ltd., in the spin-out of its drug development and medical clinics businesses into two independent public companies, Reunion Neuroscience and Field Trip Health & Wellness, by plan of arrangement. The spin-out transaction was supported by a private placement financing led by Oasis Management Company.
Wellfield Technologies Inc., in its acquisition of New Bit Ventures Ltd., d/b/a Coinmama at an agreed valuation of US$50 Million
Seamless Logic Software Limited, in its merger with MoneyClip Inc. to create Wellfield Technologies Inc., and the listing of Wellfield on the TSX Venture Exchange which was supported by a $20-million financing, bringing the total post-money valuation of Wellfield to >$100-million.
New Pacific Metals Corp., in its bought deal short form prospectus offering of common shares for total gross proceeds of $17.25 million, which included the exercise of the over-allotment option granted to the Underwriters in full.
BDC Capital Inc., in a $13 million investment on its own behalf, and $20 million in respect of the VCCI funding for an aggregate investment of $33 million in Renewal4.
BDC Capital Inc., as a key institutional investor, in a $20-million investment in ArcTern Ventures’ Fund II.
Emerald Health Therapeutics, Inc., in an at-the-market equity offering for the sale of up to $39 million of common shares pursuant to an equity distribution agreement with GMP Securities L.P.
Emerald Health acquires Québec-based Licensed Producer Agro-Biotech.